ZA898667B - Use of acetyl l-carnitine in the therapeutic treatment of cataract and pharmaceutical compositions useful in such treatment - Google Patents

Use of acetyl l-carnitine in the therapeutic treatment of cataract and pharmaceutical compositions useful in such treatment

Info

Publication number
ZA898667B
ZA898667B ZA898667A ZA898667A ZA898667B ZA 898667 B ZA898667 B ZA 898667B ZA 898667 A ZA898667 A ZA 898667A ZA 898667 A ZA898667 A ZA 898667A ZA 898667 B ZA898667 B ZA 898667B
Authority
ZA
South Africa
Prior art keywords
treatment
carnitine
acetyl
cataract
pharmaceutical compositions
Prior art date
Application number
ZA898667A
Other languages
English (en)
Inventor
Claudio Cavazza
Cavazza Claudio
Original Assignee
Sigma Tau Ind Farmaceutiche S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceutiche S filed Critical Sigma Tau Ind Farmaceutiche S
Publication of ZA898667B publication Critical patent/ZA898667B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA898667A 1988-11-15 1989-11-14 Use of acetyl l-carnitine in the therapeutic treatment of cataract and pharmaceutical compositions useful in such treatment ZA898667B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8848558A IT1235153B (it) 1988-11-15 1988-11-15 Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento

Publications (1)

Publication Number Publication Date
ZA898667B true ZA898667B (en) 1990-10-31

Family

ID=11267312

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA898667A ZA898667B (en) 1988-11-15 1989-11-14 Use of acetyl l-carnitine in the therapeutic treatment of cataract and pharmaceutical compositions useful in such treatment

Country Status (8)

Country Link
US (1) US5037851A (de)
EP (1) EP0375628B1 (de)
JP (1) JPH02180820A (de)
AT (1) ATE99172T1 (de)
DE (1) DE68911891T2 (de)
ES (1) ES2062100T3 (de)
IT (1) IT1235153B (de)
ZA (1) ZA898667B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
ATE254923T1 (de) 1998-03-19 2003-12-15 Sigma Tau Ind Farmaceuti Kombinierte zusammensetzung bestehend aus l- karnitin oder l-alkanoylkarnitin, einem glycosaminoglycan und/oder einem seiner bestandteile
JP4703851B2 (ja) * 1998-07-30 2011-06-15 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ Ｌ−カルニチンおよびそのアルカノイル誘導体の、抗癌作用を有する医薬品の製造のための使用
SK287787B6 (sk) * 2000-12-15 2011-09-05 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Použitie L-karnitínu ako stabilizačného činidla proteínov
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
AU2006265248B2 (en) * 2005-07-01 2011-12-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of L-carnitine or of alkanoyl L-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops
CN101242818B (zh) 2005-07-08 2011-09-21 希格马托制药工业公司 包含L-肉碱或烷酰基L-肉碱、脂溶性苯醌和ω-3-多不饱和脂肪酸的组合用于制备治疗角膜疾病的膳食补充剂或药物的用途
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
EP2363126A1 (de) 2010-03-04 2011-09-07 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Zusammensetzung mit L-Carnitin als aktivem Bestandteil in Kombination mit hydroxykynurenine-O-beta-DL-glucoside,zur Verhinderung und/oder Behandlung von Augenkrankheiten, die aufgrund der ultravioletten Strahlung entstanden sind
EP2642991A1 (de) 2010-11-22 2013-10-02 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutisches verfahren zur behandlung der leberschen optikusatrophie
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
EP2783695A1 (de) 2013-03-28 2014-10-01 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Physiologische Ergänzung oder Medikament zur ophthalmischen Verwendung mit L-Carnitin oder Alkanoyl-L-Carnitinen in Kombination mit Eledoisin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1184655B (it) * 1985-10-14 1987-10-28 Sigma Tau Ind Farmaceuti Imiego di acetil l-carnitina nel trattamento terapeutico degli stati di shock

Also Published As

Publication number Publication date
JPH02180820A (ja) 1990-07-13
EP0375628A2 (de) 1990-06-27
ES2062100T3 (es) 1994-12-16
ATE99172T1 (de) 1994-01-15
EP0375628A3 (de) 1991-08-14
EP0375628B1 (de) 1993-12-29
US5037851A (en) 1991-08-06
DE68911891D1 (de) 1994-02-10
DE68911891T2 (de) 1994-04-21
IT8848558A0 (it) 1988-11-15
IT1235153B (it) 1992-06-22

Similar Documents

Publication Publication Date Title
CA2004239A1 (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment
ZA898667B (en) Use of acetyl l-carnitine in the therapeutic treatment of cataract and pharmaceutical compositions useful in such treatment
AU6060896A (en) Oral 1alpha-hydroxyprevitamin D
CA2112679A1 (en) Dosage form for delivering drug in short-time period
BR9306841A (pt) Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico
EP0513702A3 (de) Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie
PT735863E (pt) Composicao de libertacao acelerada compreendendo bromocriptina
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
KR970061244A (ko) 치매 치료용 약학 조성물
CS545686A1 (en) Farmaceuticky prostredek a antihepatotoxickym pusobenim
KR970025615A (ko) 암 전이 억제제
CA2042972A1 (en) Treatment of ocular hypertension with a synergistic combination for ocular administration
IT1244636B (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
CA2180178A1 (en) Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis
ES2026304A6 (es) Procedimiento de fabricacion de una forma de dosificacion de nicardipina.
AU8687391A (en) Lithium treatment
KR950013513A (ko) 약제 제조용 모에노마이신 및 이의 유도체, 및 모에노마이신 또는 이의 유도체를 함유하는 약제
CA2120001A1 (en) Flavopereirine-based pharmaceutical composition and use thereof for treating hiv
DE3688787D1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
GR3034062T3 (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
EP0334177A3 (en) Pharmaceutical product for oral administration, particularly for the iron and magnesium substitution therapy
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
KR930019207A (ko) 카르니틴 결핍 hiv-혈청양성 환자 치료용 l-카르니틴의 용도
KR890001558A (ko) 공황(恐慌) 장애를 경감시키는 제피론 및 이의 약학적 허용 산부가염
IT1271354B (it) Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo contenente n-acetil cisteine e loro analoghi